Multivariable linear regression analysis regarding the association between PLT or WBC and the MD and further adjusted for FAC or dietary fiber intake
| Count . | Model 1 . | Model 2 . | Model 3 . | Model 4 . | ||||
|---|---|---|---|---|---|---|---|---|
| β (95% CI) . | P . | β (95% CI) . | P . | β (95% CI) . | P . | β (95% CI) . | P . | |
| PLT | ||||||||
| MDS | −1.05 (−1.65 to −0.46) | .0005 | −1.21 (−1.81 to −0.61) | <.0001 | −1.15 (−1.75 to −0.55) | .0002 | −0.85 (−1.56 to −0.135 | .020 |
| IMI | −1.21 −1.76 to −0.66) | <.0001 | −1.28 (−1.83 to −0.72) | <.0001 | −1.18 (−1.73 to −0.62) | <.0001 | −0.98 (−1.66 to −0.29) | .005 |
| WBC | ||||||||
| MDS | −0.024 (−0.04 to −0.01) | .004 | −0.022 (−0.04 to −0.01) | .008 | −0.019 (−0.03 to −0.003) | .019 | −0.009 (−0.03 to 0.01) | .33 |
| IMI | −0.042 (−0.06 to −0.03) | <.0001 | −0.039(−0.05 to −0.02) | <.0001 | −0.033 (−0.05 to −0.02) | <.0001 | −0.033 (−0.05 to −0.01) | .0003 |
| Count . | Model 1 . | Model 2 . | Model 3 . | Model 4 . | ||||
|---|---|---|---|---|---|---|---|---|
| β (95% CI) . | P . | β (95% CI) . | P . | β (95% CI) . | P . | β (95% CI) . | P . | |
| PLT | ||||||||
| MDS | −1.05 (−1.65 to −0.46) | .0005 | −1.21 (−1.81 to −0.61) | <.0001 | −1.15 (−1.75 to −0.55) | .0002 | −0.85 (−1.56 to −0.135 | .020 |
| IMI | −1.21 −1.76 to −0.66) | <.0001 | −1.28 (−1.83 to −0.72) | <.0001 | −1.18 (−1.73 to −0.62) | <.0001 | −0.98 (−1.66 to −0.29) | .005 |
| WBC | ||||||||
| MDS | −0.024 (−0.04 to −0.01) | .004 | −0.022 (−0.04 to −0.01) | .008 | −0.019 (−0.03 to −0.003) | .019 | −0.009 (−0.03 to 0.01) | .33 |
| IMI | −0.042 (−0.06 to −0.03) | <.0001 | −0.039(−0.05 to −0.02) | <.0001 | −0.033 (−0.05 to −0.02) | <.0001 | −0.033 (−0.05 to −0.01) | .0003 |
Model 1 included age and sex. Model 2 included age, sex, energy intake, BMI, physical activity, smoking, education, hypertension, diabetes, and hypercholesterolemia. Model 3 as in model 2 but further adjusted for CRP. Model 4 as in model 3 but further adjusted for FAC and dietary fiber intake. All the analyses with PLTs were further controlled for hematocrit.